Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States)

Tina Tran, Linda Titus-Ernstoff, Ann E. Perry, Marc S. Ernstoff, Irene F. Newsham

Research output: Contribution to journalArticle

Abstract

Objective: The importance of p16 alterations in the pathogenesis of dysplastic nevi and sporadic melanoma remains controversial. The goal of this work was to discover if p16/9p21 alterations occur early in precursor lesions as well as related sporadic melanomas. Methods: DNA was microdissected from 44 cutaneous melanomas, 14 dysplastic nevi, and six nevi without atypia as part of a study of melanoma. Alteration of the p16 region on 9p21 was measured by loss of heterozygosity (LOH) analysis as well as detection of homozygous deletions for p16 exon 2. Results: This analysis revealed that LOH in 9p21 directly surrounding p16 occurred in approximately 40% (17/44) of melanoma tumors representing all Clark levels. LOH was also discovered in 64% (9/14) of dysplastic nevi, and 50% (3/6) of benign nevi. Homozygous deletion of p16 was found in 29% (4/14) of dysplastic nevi but never in benign nevi. Conclusions: These studies reveal that LOH and homozygous deletion can affect 9p21 and the p16 locus early in putative precursor lesions of melanoma, even prior to the establishment of cytologically evident aberrant histology. Comparison of alterations in nevi and melanomas from the same individual revealed a pattern of progressive but heterogeneous events suggesting that systemic processes may affect this region of 9p21 at various times during melanoma progression.

Original languageEnglish (US)
Pages (from-to)675-682
Number of pages8
JournalCancer Causes and Control
Volume13
Issue number7
DOIs
StatePublished - Sep 2002
Externally publishedYes

Fingerprint

Dysplastic Nevus Syndrome
Melanoma
Chromosomes
Loss of Heterozygosity
Nevus
Nevi and Melanomas
Exons
Histology
Skin
DNA

Keywords

  • Dysplastic nevus
  • Loss of heterozygosity
  • Melanoma
  • P16

ASJC Scopus subject areas

  • Oncology
  • Epidemiology
  • Cancer Research

Cite this

Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States). / Tran, Tina; Titus-Ernstoff, Linda; Perry, Ann E.; Ernstoff, Marc S.; Newsham, Irene F.

In: Cancer Causes and Control, Vol. 13, No. 7, 09.2002, p. 675-682.

Research output: Contribution to journalArticle

Tran, Tina ; Titus-Ernstoff, Linda ; Perry, Ann E. ; Ernstoff, Marc S. ; Newsham, Irene F. / Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States). In: Cancer Causes and Control. 2002 ; Vol. 13, No. 7. pp. 675-682.
@article{9ff3163addaa474a83294b4006c408b1,
title = "Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States)",
abstract = "Objective: The importance of p16 alterations in the pathogenesis of dysplastic nevi and sporadic melanoma remains controversial. The goal of this work was to discover if p16/9p21 alterations occur early in precursor lesions as well as related sporadic melanomas. Methods: DNA was microdissected from 44 cutaneous melanomas, 14 dysplastic nevi, and six nevi without atypia as part of a study of melanoma. Alteration of the p16 region on 9p21 was measured by loss of heterozygosity (LOH) analysis as well as detection of homozygous deletions for p16 exon 2. Results: This analysis revealed that LOH in 9p21 directly surrounding p16 occurred in approximately 40{\%} (17/44) of melanoma tumors representing all Clark levels. LOH was also discovered in 64{\%} (9/14) of dysplastic nevi, and 50{\%} (3/6) of benign nevi. Homozygous deletion of p16 was found in 29{\%} (4/14) of dysplastic nevi but never in benign nevi. Conclusions: These studies reveal that LOH and homozygous deletion can affect 9p21 and the p16 locus early in putative precursor lesions of melanoma, even prior to the establishment of cytologically evident aberrant histology. Comparison of alterations in nevi and melanomas from the same individual revealed a pattern of progressive but heterogeneous events suggesting that systemic processes may affect this region of 9p21 at various times during melanoma progression.",
keywords = "Dysplastic nevus, Loss of heterozygosity, Melanoma, P16",
author = "Tina Tran and Linda Titus-Ernstoff and Perry, {Ann E.} and Ernstoff, {Marc S.} and Newsham, {Irene F.}",
year = "2002",
month = "9",
doi = "10.1023/A:1019599629895",
language = "English (US)",
volume = "13",
pages = "675--682",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "7",

}

TY - JOUR

T1 - Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States)

AU - Tran, Tina

AU - Titus-Ernstoff, Linda

AU - Perry, Ann E.

AU - Ernstoff, Marc S.

AU - Newsham, Irene F.

PY - 2002/9

Y1 - 2002/9

N2 - Objective: The importance of p16 alterations in the pathogenesis of dysplastic nevi and sporadic melanoma remains controversial. The goal of this work was to discover if p16/9p21 alterations occur early in precursor lesions as well as related sporadic melanomas. Methods: DNA was microdissected from 44 cutaneous melanomas, 14 dysplastic nevi, and six nevi without atypia as part of a study of melanoma. Alteration of the p16 region on 9p21 was measured by loss of heterozygosity (LOH) analysis as well as detection of homozygous deletions for p16 exon 2. Results: This analysis revealed that LOH in 9p21 directly surrounding p16 occurred in approximately 40% (17/44) of melanoma tumors representing all Clark levels. LOH was also discovered in 64% (9/14) of dysplastic nevi, and 50% (3/6) of benign nevi. Homozygous deletion of p16 was found in 29% (4/14) of dysplastic nevi but never in benign nevi. Conclusions: These studies reveal that LOH and homozygous deletion can affect 9p21 and the p16 locus early in putative precursor lesions of melanoma, even prior to the establishment of cytologically evident aberrant histology. Comparison of alterations in nevi and melanomas from the same individual revealed a pattern of progressive but heterogeneous events suggesting that systemic processes may affect this region of 9p21 at various times during melanoma progression.

AB - Objective: The importance of p16 alterations in the pathogenesis of dysplastic nevi and sporadic melanoma remains controversial. The goal of this work was to discover if p16/9p21 alterations occur early in precursor lesions as well as related sporadic melanomas. Methods: DNA was microdissected from 44 cutaneous melanomas, 14 dysplastic nevi, and six nevi without atypia as part of a study of melanoma. Alteration of the p16 region on 9p21 was measured by loss of heterozygosity (LOH) analysis as well as detection of homozygous deletions for p16 exon 2. Results: This analysis revealed that LOH in 9p21 directly surrounding p16 occurred in approximately 40% (17/44) of melanoma tumors representing all Clark levels. LOH was also discovered in 64% (9/14) of dysplastic nevi, and 50% (3/6) of benign nevi. Homozygous deletion of p16 was found in 29% (4/14) of dysplastic nevi but never in benign nevi. Conclusions: These studies reveal that LOH and homozygous deletion can affect 9p21 and the p16 locus early in putative precursor lesions of melanoma, even prior to the establishment of cytologically evident aberrant histology. Comparison of alterations in nevi and melanomas from the same individual revealed a pattern of progressive but heterogeneous events suggesting that systemic processes may affect this region of 9p21 at various times during melanoma progression.

KW - Dysplastic nevus

KW - Loss of heterozygosity

KW - Melanoma

KW - P16

UR - http://www.scopus.com/inward/record.url?scp=0036713522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036713522&partnerID=8YFLogxK

U2 - 10.1023/A:1019599629895

DO - 10.1023/A:1019599629895

M3 - Article

VL - 13

SP - 675

EP - 682

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 7

ER -